Several databases were also used to evaluate the target antigen in BLCA and other types of cancers.<h4>Results</h4>Based on screenings, a 6D6 clone was selected that recognized an isoform of beta-actin (ACTB). This evidence concerns the gene ACTB and bladder transitional cell carcinoma.